AFP and hepatocellular carcinoma: Vitamin K-deficient prothrombin II (PIVKA-II), which is significantly more strongly expressed in early HCC than in chronic hepatitis B, has a sensitivity of 76.3% and a specificity of 89.1% for the diagnosis of AFP-negative HCC, besides, PIVKA-II levels were associated with poor prognosis (13, 14).